Clinical Research

Esolution device S4 Medical PFA ablation esophagus

New medical device helps cardiologists limit esophageal injuries during RF ablation procedures

Injuries to the esophagus remain a common complication associated with radiofrequency ablation procedures. New research suggests a device developed by S4 Medical could significantly reduce the risk of such injuries. 

ACC 2023 ACC.23 American College of Cardiology

American College of Cardiology announces late-breaking research for ACC.24 in Atlanta

The group's annual meeting heads to Atlanta this April. TAVR, GLP-1 agonists, medical imaging guidance and blood pressure control are just some of the topics that will be presented during late-breaking sessions.

Thumbnail

Mutations in three-dimensional structures of the genome may be a cause of autism

The study involved an analysis of the genomic data from 5,000 families and could lead to new treatments.

Thumbnail

Researchers simulate red blood cells, oxygen flow using low-frequency ultrasound

Scientists from Lithuania said the therapy could be helpful for patients struggling with lung damage from COVID-19.

Isotope used in cancer drug development shipped for clinical trials

Actinium-225 remains in short supply, slowing drug research.

Thumbnail

Premature births can be predicted at 23 weeks using ultrasound

The method was developed based on 22 years of research and has been shown effective in a new study.

Thumbnail

UVA Health receives $3.1M grant for using ultrasound to deliver drugs into the brain

Researchers are aiming to use ultrasound to breach the blood-brain barrier and deliver drug therapies.

Samin Sharma, MD, director of interventional cardiology and director of clinical cardiology, Mount Sinai Hospital, New York, discusses the first-in-human use of the Magenta Elevate percutaneous left ventricular assist device (pLVAD) with a small 10 French size and 5.5 liters per minute of hemodynamic support.

Initial results promising for world's smallest percutaneous heart pump

A new 10 French percutaneous heart pump could help greatly reduce vascular complications and improve cardiogenic shock outcomes.